The antibiotic resistance diagnosis devices market is projected to grow from USD 361.1 million in 2025 to USD 599.5 million by 2035, at a CAGR of 5.2%. AST Devices will dominate with a 41.8% market share, while hospital will lead the application segment with a 47.3% share.